all statistical analyses used, but the authors need to specify which test was used for which purpose. For example, 'a twosample independent t-test was used to compare continuous data between two groups' tells the reader what can be read from any statistical textbook, but does not tell the reader for which comparison the authors used a t-test, and if an independent-samples t-test was thus the appropriate test. The author needs to specify for which study-specific aim the statistical test was used, for example 'a two-sample independent t-test was used to compare the bodyweight between patients and controls'.
Always Be Clear when reporting the results
Results should be described in such a way that they can be incorporated into other analyses. 4 For reported data to be reused for meta-analyses, the numerators and denominators of percentages, risks, odds ratios and hazards ratios must be provided. Also, reporting P-values only is not sufficient: descriptive statistics of the groups, sample size and effect size, and a measure of precision (standard error or 95% confidence interval) should be reported. In addition, actual P-values should be reported, rather than referencing P-values to a critical value (e.g. P = 0Á006 instead of P < 0Á05).
Clinical Trials: Always Be Clear about the analysis plan and interpretation of results
For sake of transparency, authors should develop a statistical analysis plan, a prospective document that specifies how the trial data will be analysed. 5 The analysis plan could either be a stand-alone document or be integrated into the protocol. The document should be signed off before blindness is to be broken, and before any analysis has started. Any deviations from the signed-off plan should be clearly explained. Adherence to the CONSORT reporting guidelines facilitates transparency of reporting, and genuine and accurate interpretation of results. 6 In most of the clinical trial papers submitted to the BJD in 2017-2018, the CONSORT 2010 checklist, which is appropriate only for individually randomized, twogroup, parallel trials, was completed. 6 Extended CONSORT checklists have been developed for: (i) other designs such as cluster randomized trials, noninferiority and equivalent trials, or pilot studies and (ii) other interventions including nonpharmacological treatment, herbal medicine or acupuncture. Given the continuous evolving nature of the CONSORT guidelines, authors are strongly recommended to visit the CON-SORT website to be sure the most up-to-date checklist is used.
Epidemiology: Always Be Clear about assumptions in regression analyses
Regression analyses are frequently used in epidemiological studies. In the methods, authors need to state how the model assumptions were tested, if they were met and (if applicable) what was done when the assumptions were not met. For linear regression analyses these assumptions include independence of observations, linear relationship between covariate and outcome, normal distribution of the residuals (differences between the observed and predicted values) and the same SD of the residuals across every value of the predictor (homoscedasticity). 7 The linearity assumption also applies to other regression models (e.g. logistic, Cox, Poisson). Nonlinear relationships can be included in regression models by including nonlinear functions (most accurate) or categorizing continuous variables (simple, easy to interpret). When a Cox proportional hazards model is applied to survival data, the proportional hazards assumption should be tested. Genomics: Always Be Clear about your analysed DNA and RNA data given the very 'noisy' background Whole-exome sequencing and whole-genome sequencing methods are used to detect causative DNA mutations in an individual. These procedures provide a long list of variants in the DNA of the tested individual. The list of variants is dependent firstly on the depth of the run. For example, an average of 100-times coverage over the DNA would generate more variants than a 20-times coverage read. The list of variants is also dependent on the similarity to the reference DNA. For example, an African American DNA aligned against a European reference DNA would generate a vast amount of nonmatching variants. These and other parameters affect the probability of locating a detrimental causative mutation and should therefore be reported in the methods. Changes in cellular RNA levels reveal information on the state and function of samples. Most commonly used is the expression analysis of mRNA using sequencing technologies (RNA-Seq), which allows biologists to identify gene and transcript expression under two or more conditions, and also to identify new genes and new splice variants. RNA-Seq experiments must be analysed with robust, efficient and statistically principled algorithms. Fortunately, the bioinformatics community has developed mathematical and statistical tools for RNA-Seq processing presented as downloadable software or online tools, which must be specified in the methods section. Many other sophisticated procedures prior to data generation increase biological insight. For example, CLIP (cross-linking immunoprecipitation) is used in order to analyse protein interactions with RNA. 9 These should be clearly described in the manuscript.
Systematic Reviews and Meta-Analyses:
Always Be Clear about the analytical methods for pooling studies
The choice over using a fixed or random effects models needs to be declared within the methods section. Random effects models should be the default, as this model allows for the magnitude of effect for the treatment or association to vary by study and patient-level characteristics. The fixed effects model should be used only where there is a strong rationale that there could be a single magnitude of effect for the treatment or association being investigated. It is important that the variation between studies, known as heterogeneity, is fully investigated; 10 two methods commonly used are subgroup analysis and sensitivity analysis. Subgroup analysis is used to determine whether the pooled effect size varies between subgroups, for example high vs. low methodological quality, using a statistical test. In contrast, a sensitivity analysis compares the magnitude of the pooled effect between a restricted set of studies, for example where studies of poorer methodological quality are excluded, and the magnitude of the pooled effect from the overall meta-analysis. It is important that the characteristics to be investigated are biologically plausible and specified a priori. The results from subgroup and sensitivity analyses should be treated only as exploratory, as there is the potential for an association to be found purely by chance or due to other confounding factors.
Translational Research: Always Be Clear about accounting for multiplicity in hypothesis testing
Most studies do not test a single hypothesis, but rather cast a wide net for interesting associations. It is absolutely not valid to perform all tests at the nominal level of significance required (which is typically 0Á05) and declare as significant associations that pass this threshold. This invalidity is easy to state and explain, as performing 50 tests at level 0Á05 essentially guarantees that some findings will be made, even if there is nothing to find (from the definition of what the test level means). What should be done to correct this may be scenario-dependent and in some cases can be hard to figure out. The simplest adjustment is the Bonferroni correction (dividing the alpha-level by the number of tests). In some cases, Benjamini-Hochberg-type methods for controlling the false discovery rate can also be appropriate. 11 More advanced aspects include accounting for exploratory analysis and dividing the tests into 'primary' and 'secondary' analyses, which can drive complex, but still valid, testing schemes.
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Always Be Clear about the use of reporting guidelines
Reporting guidelines include many of the aforementioned statistical and methodological items, which should be described in your manuscript. 3 All recommended reporting guidelines can be found in the BJD author guidelines. 2 The use of reporting guidelines will contribute to manuscripts with transparently reported methods and results, which are always clear!
